Patients newly diagnosed with PAH are often undertreated relative to treatment recommendations outlined in current guidelines.

Illustration and principle of the subcutaneous and continuous BP monitoring by PMUTs in an ambulatory sheep. a The PMUT device is implanted subcutaneously near the sheep’s femoral artery to emit ...

Please provide your email address to receive an email when new articles are posted on . Advancements in treatment directed by risk stratification and the availability of novel targeted therapy provide ...

Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the arteries in your lungs. It happens when these arteries become narrow or blocked, making it harder for blood to flow ...

DEAR DR. ROACH: Nine days ago, I had a medical procedure under general anesthesia. One of the lines was put in the artery in my left wrist. Aside from deep bruising that went halfway up my forearm, it ...

In patients with pulmonary arterial hypertension (PAH), the use of anticoagulants was not associated with improvement in overall survival, and these results were confirmed by an updated meta-analysis.

Sotatercept, an activin-signaling inhibitor, reduces morbidity and mortality among patients with long-standing pulmonary arterial hypertension. Its effects in patients with pulmonary arterial ...

Please provide your email address to receive an email when new articles are posted on . CS1 is an oral histone deacetylase inhibitor that has been shown to be well tolerated in patients with PAH in a ...

The U.S. military recently used its new Protected Tactical Waveform (PTW) to successfully demonstrate some of the key elements of the modernized anti-jam waveform, U.S. Space Force Space Systems ...

The incidence of pulmonary arterial hypertension (PAH) has increased worldwide over the past three decades, although death rates and disability-adjusted life year (DALY) rates related to the disease ...

1 Division of Cardiovascular Intensive Care, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan 2 Department of Cardiovascular Dynamics, National ...